Dr. Thomas White, MD

NPI: 1568485365
Total Payments
$80,547
2024 Payments
$5,643
Companies
21
Transactions
210

Payment Breakdown by Category

Other$67,185 (83.4%)
Food & Beverage$7,074 (8.8%)
Travel$5,626 (7.0%)
Consulting$500.00 (0.6%)
Education$162.29 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $67,185 35 83.4%
Food and Beverage $7,074 132 8.8%
Travel and Lodging $5,626 28 7.0%
Consulting Fee $500.00 1 0.6%
Education $162.29 14 0.2%

Top Paying Companies

Company Total Records Latest Year
Amarin Pharma Inc. $50,491 94 $0 (2023)
Amgen Inc. $18,273 39 $0 (2024)
Janssen Pharmaceuticals, Inc $9,065 24 $0 (2019)
Medicure Pharma Inc. $600.00 2 $0 (2019)
Novo Nordisk Inc $496.04 13 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $424.53 4 $0 (2024)
Regeneron Healthcare Solutions, Inc. $348.61 4 $0 (2022)
SANOFI-AVENTIS U.S. LLC $262.21 5 $0 (2019)
Biohaven Pharmaceutical Holding Company Ltd. $119.41 1 $0 (2022)
Esperion Therapeutics, Inc. $118.27 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,643 10 Amgen Inc. ($5,379)
2023 $12,166 21 Amgen Inc. ($12,009)
2022 $754.43 12 Novo Nordisk Inc ($308.40)
2021 $306.72 6 Esperion Therapeutics, Inc. ($102.53)
2020 $4,505 12 Amarin Pharma Inc. ($4,475)
2019 $14,145 34 Amarin Pharma Inc. ($13,109)
2018 $17,092 47 Amarin Pharma Inc. ($16,386)
2017 $25,936 68 Amarin Pharma Inc. ($16,385)

All Payment Transactions

210 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
09/24/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $150.83 General
Category: Cardiology
08/28/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.60 General
Category: Cardiology/Vascular Diseases
07/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $102.35 General
Category: DIABETES
02/27/2024 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Cardiology
02/27/2024 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Cardiology
02/21/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $10.66 General
Category: Cardiology
01/31/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $125.56 General
Category: DIABETES
01/30/2024 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Cardiology
01/29/2024 Novo Nordisk Inc Saxenda (Drug), Wegovy Food and Beverage In-kind items and services $18.41 General
Category: Obesity
01/18/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.09 General
Category: Cardiology
12/27/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: Cardiology
12/14/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Cardiology
12/14/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Cardiology
12/14/2023 Amgen Inc. Repatha (Biological) Travel and Lodging Cash or cash equivalent $53.19 General
Category: Cardiology
12/08/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.38 General
Category: Cardiology
12/05/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Cardiology
12/05/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Cardiology
11/30/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
10/26/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $120.62 General
Category: Cardiology
10/17/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Cardiology
10/17/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Cardiology
10/12/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $120.65 General
Category: Cardiology
09/27/2023 Amgen Inc. Repatha (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: Cardiology
09/08/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $91.91 General
Category: Cardiology
08/18/2023 Amgen Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $200.00 General

About Dr. Thomas White, MD

Dr. Thomas White, MD is a Family Medicine healthcare provider based in Cherryville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568485365.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas White, MD has received a total of $80,547 in payments from pharmaceutical and medical device companies, with $5,643 received in 2024. These payments were reported across 210 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,185).

Practice Information

  • Specialty Family Medicine
  • Location Cherryville, NC
  • Active Since 07/25/2006
  • Last Updated 11/20/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1568485365

Products in Payments

  • Vascepa (Drug) $50,491
  • Repatha (Biological) $17,575
  • INVOKANA (Drug) $8,936
  • ZYPITAMAG (pitavastatin) (Drug) $600.00
  • JARDIANCE (Drug) $424.53
  • PRALUENT ALIROCUMAB INJECTION (Biological) $329.62
  • Prolia (Biological) $225.47
  • Ozempic (Drug) $147.38
  • PRALUENT (Drug) $139.40
  • XARELTO (Drug) $128.66
  • NURTEC ODT (Drug) $119.41
  • NEXLETOL (Drug) $118.27
  • DISEASE STATE (Drug) $108.26
  • Aimovig (Biological) $100.94
  • Saxenda (Drug) $95.82
  • Trintellix (Drug) $90.71
  • PRALUENT (Biological) $79.21
  • Victoza (Drug) $57.31
  • TRULICITY (Drug) $28.84
  • Livalo (Drug) $26.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.